ZA897886B - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
ZA897886B
ZA897886B ZA897886A ZA897886A ZA897886B ZA 897886 B ZA897886 B ZA 897886B ZA 897886 A ZA897886 A ZA 897886A ZA 897886 A ZA897886 A ZA 897886A ZA 897886 B ZA897886 B ZA 897886B
Authority
ZA
South Africa
Prior art keywords
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
ZA897886A
Other languages
English (en)
Inventor
David Ian Carter Scopes
Ian Carter Scopes David
Duncan Bruce Judd
Bruce Judd Duncan
David John Belton
John Belton David
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA897886B publication Critical patent/ZA897886B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA897886A 1988-10-18 1989-10-18 Heterocyclic compounds ZA897886B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888824400A GB8824400D0 (en) 1988-10-18 1988-10-18 Chemical compounds

Publications (1)

Publication Number Publication Date
ZA897886B true ZA897886B (en) 1990-09-26

Family

ID=10645389

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA897886A ZA897886B (en) 1988-10-18 1989-10-18 Heterocyclic compounds

Country Status (12)

Country Link
US (1) US5109008A (xx)
EP (1) EP0366327A1 (xx)
JP (1) JPH02191278A (xx)
KR (1) KR900006341A (xx)
AU (1) AU629585B2 (xx)
CA (1) CA2000894A1 (xx)
DK (1) DK517989A (xx)
FI (1) FI894960A0 (xx)
GB (1) GB8824400D0 (xx)
NZ (1) NZ231056A (xx)
PT (1) PT92010A (xx)
ZA (1) ZA897886B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827479D0 (en) * 1988-11-24 1988-12-29 Zambeletti Spa L Novel compounds
GB8926560D0 (en) * 1989-11-24 1990-01-17 Zambeletti Spa L Pharmaceuticals
ATE148463T1 (de) * 1989-11-24 1997-02-15 Smithkline Beecham Spa N-acyl-substituierte azazyklische verbindungen, verfahren zu deren herstellung und deren verwendung als arzneimittel
WO1991017116A1 (en) * 1990-04-28 1991-11-14 Dr. Lo. Zambeletti S.P.A. Novel 1-(2h-1-oxo-3,4-dihydronaphtyl-6)-acetyl-piperidines, process for their preparation and therapeutic use
US5122088A (en) * 1991-01-28 1992-06-16 Meline Ralph E Mute for an elk call
GB9104839D0 (en) * 1991-03-07 1991-04-17 Zambeletti Spa L Novel compounds
WO1994002461A1 (en) * 1992-07-28 1994-02-03 Merck Sharp & Dohme Limited Azacyclic compounds
DE4328228A1 (de) * 1993-08-23 1995-03-02 Basf Ag Verfahren zur Herstellung von Pyrazol und dessen Derivaten
IT1273751B (it) * 1994-02-11 1997-07-10 Smithkline Beecham Farma Derivati azaciclici
US5763445A (en) * 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5646151A (en) * 1996-03-08 1997-07-08 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US6750216B2 (en) 1996-03-08 2004-06-15 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US6239154B1 (en) 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
USRE38133E1 (en) * 1996-03-08 2003-06-03 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US5688955A (en) * 1996-03-08 1997-11-18 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US6303611B1 (en) 1996-03-08 2001-10-16 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US6057323A (en) * 1996-03-08 2000-05-02 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
BR9810706A (pt) * 1997-07-14 2000-08-08 Adolor Corp Processo para a prevenção ou tratamento do prurido em um mamìfero em necessidade de tal prevenção ou tratamento
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
KR100295740B1 (ko) 1998-09-17 2001-11-05 박영구 N-치환된-하이드록시고리화알킬아민유도체의제조방법
KR100939347B1 (ko) 2005-07-20 2010-01-29 (주)카이로드 광학적으로 순수한 (s)-3-히드록시 피롤리딘의 제조방법
JP5779100B2 (ja) 2008-11-24 2015-09-16 カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ 光学的に活性なn−ベンジル−3−ヒドロキシピロリジンの製造方法
NZ731621A (en) 2009-12-04 2019-01-25 Sunovion Pharmaceuticals Inc Multicyclic compounds and methods of use thereof
KR20190065246A (ko) 2016-07-29 2019-06-11 선오비온 파마슈티컬스 인코포레이티드 화합물 및 조성물 및 이들의 용도
IL264446B1 (en) 2016-07-29 2024-05-01 Pgi Drug Discovery Llc Compounds and compositions and their use
IL268694B2 (en) 2017-02-16 2023-10-01 Sunovion Pharmaceuticals Inc Treatment of schizophrenia
EP3661929B1 (en) 2017-08-02 2021-07-14 Sunovion Pharmaceuticals Inc. Isochroman compounds and uses thereof
WO2019161238A1 (en) 2018-02-16 2019-08-22 Sunovion Pharmaceuticals Inc. Salts, crystal forms, and production methods thereof
AU2020236225A1 (en) 2019-03-14 2021-09-16 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
US11738002B2 (en) 2020-04-14 2023-08-29 Sunovion Pharmaceuticals Inc. Methods of treating neurological and psychiatric disorders

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845065A (en) * 1972-02-18 1974-10-29 Merck & Co Inc 4-oxo-4,5-dihydrothieno(3,2-c)pyridines
US3903095A (en) * 1972-02-18 1975-09-02 Merck & Co Inc Certain substituted-thieno{8 3,2-c{9 -pyridines
FR2215948B1 (xx) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma
FR2395028A2 (fr) * 1977-06-22 1979-01-19 Centre Etd Ind Pharma Derives pyridiniques, leur preparation et leurs application therapeutique
US4579863A (en) * 1983-12-06 1986-04-01 Warner-Lambert Company Substituted trans-1,2-diaminocyclohexyl amide compounds
US4618621A (en) * 1984-09-21 1986-10-21 The Upjohn Company Method for treating medical conditions involving cerebral ischemia
GB8531615D0 (en) * 1985-12-23 1986-02-05 Zambeletti Spa L Compounds
FR2592879B1 (fr) * 1986-01-13 1988-04-29 Roussel Uclaf Nouveaux derives de la decahydroquinoleine, leur procede de preparation, les intermediaires de preparation, leur application a titre de medicaments et les compositions les renfermant
GB8601796D0 (en) * 1986-01-24 1986-02-26 Zambeletti Spa L Compounds
DE3767816D1 (de) * 1986-09-02 1991-03-07 Zambeletti Spa L 1-acylsubstituierte piperidinderivate.
EP0271273A3 (en) * 1986-12-08 1989-07-12 Merck & Co. Inc. Thieno-and furopyridine sulfonamides
US4731368A (en) * 1986-12-08 1988-03-15 Merck & Co., Inc. Thienopyridine sulfonamides and their ophthalmological formulation
DK674487A (da) * 1986-12-22 1988-06-23 Zambeletti Spa L Piperidinderivater
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
ATE97893T1 (de) * 1988-02-19 1993-12-15 Smithkline Beecham Farma 1,2,3,4-tetrahydroisoquinoline, verfharen zu ihrer herstellung und ihre verwendung als kappa- rezeptor agonisten.
EP0333427B1 (en) * 1988-03-16 1995-08-23 Smithkline Beecham Farmaceutici S.p.A. Heterocyclic derivatives

Also Published As

Publication number Publication date
CA2000894A1 (en) 1990-04-18
AU4294889A (en) 1990-04-26
US5109008A (en) 1992-04-28
DK517989A (da) 1990-04-19
DK517989D0 (da) 1989-10-18
KR900006341A (ko) 1990-05-08
FI894960A0 (fi) 1989-10-18
EP0366327A1 (en) 1990-05-02
AU629585B2 (en) 1992-10-08
NZ231056A (en) 1992-02-25
GB8824400D0 (en) 1988-11-23
JPH02191278A (ja) 1990-07-27
PT92010A (pt) 1990-04-30

Similar Documents

Publication Publication Date Title
GB8916722D0 (en) Heterocyclic compounds
GB8826205D0 (en) Heterocyclic compounds
ZA897886B (en) Heterocyclic compounds
GB8814458D0 (en) Heterocyclic compounds
EP0431707A3 (en) Heterocyclic compounds
GB8922996D0 (en) Heterocyclic compounds
EP0428339A3 (en) Heterocyclic compounds
AP9000220A0 (en) Heterocyclic compounds
GB9124015D0 (en) Heterocyclic compounds
ZA898438B (en) Heterocyclic compounds
GB8914737D0 (en) Heterocyclic compounds
EP0435041A3 (en) Heterocyclic compounds
GB8824403D0 (en) Heterocyclic compounds
GB9124014D0 (en) Heterocyclic compounds
GB8821940D0 (en) Heterocyclic compounds
GB8822564D0 (en) Heterocyclic compounds
GB8823682D0 (en) Heterocyclic compounds
GB8823683D0 (en) Heterocyclic compounds
GB8823684D0 (en) Heterocyclic compounds
GB8819660D0 (en) Heterocyclic compounds
GB8817483D0 (en) Heterocyclic compounds
GB8824669D0 (en) Heterocyclic compounds
GB8816772D0 (en) Heterocyclic compounds
GB8809036D0 (en) Heterocyclic compounds
GB8808796D0 (en) Heterocyclic compounds